Pharmaceutical Industry in UK – Porter's Five Forces Strategy Analysis 2017 – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Pharmaceutical
Industry in UK – Porter’s Five Forces Strategy Analysis”
to their offering.

The pharmaceutical industry in the UK has been witnessing a decline in
recent years, even though the UK is home to many of the world’s leading
pharma companies such as GSK and AstraZeneca. The UK has one of the
biggest Research and Development expenditures amongst any European

This research analyzes the Pharmaceutical Industry in UK in the Michael
Porter’s Five Forces Analysis. It uses concepts developed in Industrial
Organization (IO) economics to derive five forces that determine the
competitive intensity and therefore attractiveness of a market. Porter
referred to these forces as the microenvironment, to contrast it with
the more general term macroenvironment. They consist of those forces
close to a company that affect its ability to serve its customers and
make a profit. A change in any of the forces normally requires a company
to re-assess the marketplace.

Key Topics Covered:

A. Executive Summary

B. Introduction to the Industry

B.1 Industry Definition

B.2 Industry Profile

B.3 Future Outlook

C. Porter’s Five Forces Strategy Analysis

C.1 Bargaining Power of Buyers

C.2 Bargaining Power of Suppliers

C.3 Competitive Rivalry in the Industry

C.4 Threat of New Entrants

C.5 Threat of Substitutes

D. Conclusion

E. Glossary of Terms

For more information about this report visit


Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Topics: Pharmaceuticals